Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity

Human Pathology

Volumn 29, Issue 11, 1998, Pages 1189-1194

  Staibano, Stefania ^a   Mignogna, Michele Davide ^a   Lo Muzio, Lorenzo ^a   Di Alberti, Luca ^a   Di Natale, Enrico ^a   Lucariello, Antonio ^a   Mezza, Ernesto ^a   Bucci, Eduardo ^a   Derosa, Gaetano ^a  

^a NONE

Author keywords

Bcl 1; Bcl 2; DNA ploidy; Oral SCC; PCNA

Indexed keywords

CYCLIN D1; CYCLINE; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION; SEX RATIO; SQUAMOUS CELL CARCINOMA;

EID: 0031788261     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90244-1     Document Type: Article

References (54)

1. Lee G, Wong YK, Chang YL, et al: Metastasis in oral squamous cell carcinoma. Chung Hua I Hsueh Tsa Chih Taipei 48:445-450, 1991
2. Lese CM, Rossie KM, Appel BN, et al: Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosom Cancer 12:288-295, 1995
3. Alitalo K, Schwab M: Oricogene amplification in tumor cells. Adv Cancer Res 47:235-281, 1986
4. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1981
5. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235:177-182, 1987
6. Zhou D, Battifora H, Yokota J, et al: Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 47:6123-6125, 1987
7. Escot C, Theillet C, Lidereau R, et al: Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci U S A 83:4834-4838, 1986
8. Yokota J, Tsunetsugu-Yokota Y, Battifora H, et al: Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science 231:261-265, 1986
9. Zatterstrom UK, Wennerberg J, Ewers SB, et al: Prognostic factors in head and neck cancer: Histologic grading, DNA ploidy, and nodal status. Head Neck 13:477-487, 1991
10. Barona de Guzman R, Martorell MA, Basterra J, et al: Analysis of DNA content in supraglottic epidermoid carcinoma. Otolaryngol Head Neck Surg 108:706-710, 1993
11. Lampe HB: DNA analysis of head and neck squamous cell carcinoma by flow cytometry. Laryngoscope 103:637-644, 1993
12. Tytor M, Olofsson J, Ledin T, et al: Squamous cell carcinoma of the oral cavity. A review of 176 cases with application of malignancy grading and DNA measurements. Clin Otolaryngol 15:235-252, 1990
13. Sickle-Santanello BJ, Farrar WB, Dobson JL, et al: Flow cytometric analysis of DNA content as a prognostic indicator in squamous cell carcinoma of the tongue. Am J Surg 152:393-395, 1986
14. Burgio DL, Jacobs JR, Maciorowski Z, et al: DNA ploidy of primary and metastatic squamous cell head and neck cancers. Arch Otolaryngol Head Neck Surg 118:185-187, 1992
15. Berger MS, Locher GW, Saurer S, et al: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238-1243, 1988
16. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991
17. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
18. Böcking A, Adler CP, Common HH, et al: Algorithm for a DNA-photocytometric diagnosis and grading of malignancy. Anal Quant Cytol Histol 6:1-8, 1984
19. Nowell PC: Cytogenetics of tumor progression. Cancer 65: 2172-2177, 1990
20. Sasaki-K, Murakami-T, Murakami-T, et al: Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinomas. Cancer 68:2403-2406, 1991
21. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7:139-146, 1993
22. Berenson JR, Yang J, Mickel RA: Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4:1111-1116, 1989
23. Bosch F, Jares P, Campo E, et al: PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mande cell lymphoma. Blood 84:2726-2732, 1994
24. Hockenbery DM, Zutter M, Hickey W, et al: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965; 1991
25. Callender T, el-Naggar AK, Lee MS, et al: PRAD-1 (CCND1)/ cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152-158, 1994
26. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
27. Monaghan P, Robertson D, Amos TA, et al: Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40:1819-1825, 1992
28. Alnemri ES, Robertson NM, Fernandes TF, et al: Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci USA 89:7295-7299, 1992
29. Jacobson MD, BurneJF, King MP, et al: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-369, 1993
30. Delia D, Aiello A, Soligo D, et al: Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291-1298, 1992
31. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988
32. Lam M, Dubyak G, Chen L, et al: Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci U S A 91:6569-6573, 1994
33. Crowson AN, Magro CM, Kadin ME, et al: Differential expression of the bcl-2 oncogene in human basal cell carcinoma. HUM PATHOL 27:355-359, 1996
34. Birchall MA, Schock E, Harmon BV, et al: Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: Prospective, in vivo study. Oral Oncol 33:419-425, 1997
35. Alcade RE, Shintani S, Yoshihama Y, et al: Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Anticancer Res 15:1417-1422, 1995
36. Coltrera MD, Skelly M, Gown AM: Anti-PCNA antibody PC10 yields unreliable proliferation indices in rutinely processed, deparaffinized, formalin-fixed tissue. Appl Immunohistochem1:193-200, 1993
37. Burford-Mason AP, Mackey AJ, Cummins M, et al: Detection of proliferating cell nuclear antigen in paraffin-embedded specimens is dependent on pre-embedding tissue handling and fixation. Arch Pathol Lab Med 118:1007-1013, 1994
38. Dorman AM, Walsh TN, Droogan O, et al: DNA quantification of squamous cell carcinoma of the oesophagus by flow cytometry and cytophotometric image analysis using formalin fixed paraffin embedded tissue. Cytometry 13:886-892, 1992
39. Dorman A, Graham D, Curran B, et al: Ploidy of smooth muscle tumours: Retrospective image analysis study of formalin fixed, paraffin wax embedded tissue. J Clin Pathol 43:465-468, 1990
40. Welkoborsky HJ, Hinni M, Dienes HP, et al: Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104:503-510, 1995
41. Holm LE: Cellular DNA amounts of SCC of the head and neck region in relation to prognosis. Laryngoscope 92:1064-1069, 1982
42. Munck-Wikland E, Auer G, Kuylenstierna R, et al: Image cytometry DNA analysis of invasive squamous cell carcinoma of the esophagus. Anticancer Res 9:545-549, 1989
43. Franzen G, Olofsson J, Klintenberg C, et al: Prognostic value of malignancy grading and DNA measurements in small glottic carcinomas. ORLJ Otorhinolaryngol Relat Spec 49:73-80, 1987
44. Truelson JM, Fisher SG, Beals TE, et al: DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. Cancer 70:56-62, 1992
45. Umehara Y, Miyahara T, Yoshida M, et al: An analysis of the cellular DNA contents in lung-metastasized stomach cancers. Gan No Rinsho 36:469-472, 1990
46. Rube C, Valet G, Eder M: Cellular DNA content and metastasis pattern in colorectal carcinomas. Virchows Arch A Pathol Anat Histopathol 413:419-424, 1988
47. Auer GU, Arrhenius E, Granberg PO, et al: Comparison of DNA distributions in primary human breast cancers, and their metastases. EurJ Cancer 16:273-278, 1980
48. Kuo SH, Sheu JC, Chen DS, et al: DNA clonal heterogeneity of hepatocellular carcinoma demonstrated by Fculgen-DNA analysis. Liver 7:359-363, 1987
49. Joerg H, Joachim K: Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Cancer 66:317-320, 1990
50. Ensley JF: The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 15:133-141, 1996
51. Mikami Y, Tsukuda M, Ito K, et al: Peritumoral angiogenesis in carcinomas of the head and neck. Auris Nasus Larynx 23:57-62, 1996
52. Sarker SK, Ghufoor K, Patel KS, et al: Nuclear content using computerized image cytometry of squamous cell carcinomas of the head and neck. J Laryngol Otol 111:43-47, 1997
53. Hemmer J, Thein T, Van Heerden WF: The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma. Cancer 79:2309-2313, 1997
54. Kao-Shan CS, Fine RL, Whang-Peng J, et al: Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 47:6278-82, 1987